ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39636-50mg |
|
1801333-55-0 |
PF-06952229
|
0 | C23H24ClFN4O3 | |
GC39636-10mg |
|
1801333-55-0 |
PF-06952229
|
0 | C23H24ClFN4O3 | |
GC39636-5mg |
|
1801333-55-0 |
PF-06952229
|
0 | C23H24ClFN4O3 | |
GC39635-100mg |
|
1931946-73-4 |
PC945
|
0 | C38H37F3N6O3 | |
GC39635-50mg |
|
1931946-73-4 |
PC945
|
0 | C38H37F3N6O3 | |
GC39635-10mg |
|
1931946-73-4 |
PC945
|
0 | C38H37F3N6O3 | |
GC39635-5mg |
|
1931946-73-4 |
PC945
|
0 | C38H37F3N6O3 | |
GC39634-100mg |
|
1655504-04-3 |
Orelabrutinib
|
0 | C26H25N3O3 | |
GC39634-50mg |
|
1655504-04-3 |
Orelabrutinib
|
0 | C26H25N3O3 | |
GC39634-10mg |
|
1655504-04-3 |
Orelabrutinib
|
0 | C26H25N3O3 | |
GC39634-5mg |
|
1655504-04-3 |
Orelabrutinib
|
0 | C26H25N3O3 | |
GC39633-100mg |
|
877950-01-1 |
LtaS-IN-1
|
0 | C24H17N3O5 | |
GC39633-50mg |
|
877950-01-1 |
LtaS-IN-1
|
0 | C24H17N3O5 | |
GC39633-10mg |
|
877950-01-1 |
LtaS-IN-1
|
0 | C24H17N3O5 | |
GC39633-5mg |
|
877950-01-1 |
LtaS-IN-1
|
0 | C24H17N3O5 | |
GC39632-100mg |
|
147076-36-6 |
Laflunimus
|
0 | C15H13F3N2O2 | |
GC39632-50mg |
|
147076-36-6 |
Laflunimus
|
0 | C15H13F3N2O2 | |
GC39632-10mg |
|
147076-36-6 |
Laflunimus
|
0 | C15H13F3N2O2 | |
GC39632-5mg |
|
147076-36-6 |
Laflunimus
|
0 | C15H13F3N2O2 | |
GC39631-100mg |
|
— |
GNE-1858
|
0 | C21H26F2N8 | |